- $106.31m
- $86.28m
- $19.61m
Brief: iCAD, CancerIQ Partner to Integrate AI-Enabled Technology With Risk Assessment and Care Management Platform
Advisory: Research alert on ICAD Inc withdrawn
Brief: ICAD, Inc. Announces Sale Of Xoft, Its Brachytherapy Business Line, To Elekta
Icad Inc Reports Results For The Quarter Ended In June: Earnings Summary
Icad Inc Expected To Post A Loss Of 11 Cents A Share: Earnings Preview
Brief: Icad Inc Says May Offer And Sell Shares Of Common Stock With Aggregate Offering Price Of Up To $25 Million From Time To Time
Brief: Icad Inc Files For Mixed Shelf Of Up To $100 Million
Brief: ICAD Signs Strategic Commercial Agreement With Radiology Partners, Nation’s Largest Radiology Practice
Icad Inc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: Icad Reports Financial Results For First Quarter
Icad Inc Expected To Post A Loss Of 11 Cents A Share: Earnings Preview
iCAD appoints insider Eric Lonnqvist as CFO, shares up
Brief: Icad Strengthens Leadership Team With Appointment Of Chief Financial Officer And New Senior Executives
U.S. RESEARCH ROUNDUP- Enliven Therapeutics, Lululemon Athletica, Walgreens
Brief: Icad Posts Q4 Loss Of $0.12 Per Share
Icad Inc Reports Results For The Quarter Ended In December: Earnings Summary
Brief: Icad Inc - Plans To Reduce Its Workforce By Approximately 28%, Decreasing Its Headcount By Approximately 23 Employees
Icad Inc Expected To Post A Loss Of 14 Cents A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-Moderna, Genie Energy, Merck & Co